ArticleNucleic acids research2026
Machine learning-driven optimization of specific, compact, and efficient base editors via single-round diversification.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Base editing shows great potential in research and clinical applications. Current iterations of the deaminases used to create precise single-nucleotide changes via base editing exhibit undesirable effects, including off-targeting, off-base editing, and bystander editing. Current deaminases are derived from either larger eukaryotic deaminases, which exhibit high levels of Cas-independent DNA targeting, or from evolved variants of the smaller Escherichia coli TadA protein (ecTadA), which exhibits off-base editing. To overcome the limitations inherent to using a single protein sequence for engineering, we diversified newly identified TadA orthologs by DNA shuffling to yield millions of training sequences for measuring base editor efficiency. We trained generative models on the performance data from the pools of variants and drew on information-theoretic insights to efficiently explore the sequence space to generate diverse and high-performing deaminases. From a single round of diversification, we created a small set of novel and specific cytosine and adenosine deaminases that were markedly distinct in sequence from published base editor deaminases. We found that our model-created deaminases generally outperform those we identified through typical directed evolution. The novel compact deaminases identified here show high on-base activity, comparable to the leading published base editors, and with demonstrably lower off-base activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.